Name | 3-[2-[4-[(E)-C-(2,4-difluorophenyl)-N-hydroxycarbonimidoyl]piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one |
---|---|
Synonyms |
4H-Pyrido[1,2-a]pyrimidin-4-one, 3-[2-[4-[(E)-(2,4-difluorophenyl)(hydroxyimino)methyl]-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-
3-(2-{4-[(E)-(2,4-Difluorophenyl)(hydroxyimino)methyl]-1-piperidinyl}ethyl)-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one |
Description | Risperidone E-oxime is an impurity of Risperidone[1]. Risperidone is a serotonin 5-HT2 receptor blocker, P-Glycoprotein inhibitor and potent dopamine D2 receptor antagonist, with Kis of 4.8, 5.9 nM for 5-HT2A and dopamine D2 receptor, respectively [2][3]. |
---|---|
Related Catalog | |
References |
[1]. Pavel Slanina, et al. Process for making risperidone and intermediates therefor. US20040097523A1. |
Density | 1.3±0.1 g/cm3 |
---|---|
Boiling Point | 569.0±60.0 °C at 760 mmHg |
Molecular Formula | C23H28F2N4O2 |
Molecular Weight | 430.491 |
Flash Point | 297.9±32.9 °C |
Exact Mass | 430.218048 |
PSA | 79.68000 |
LogP | 3.16 |
Vapour Pressure | 0.0±1.6 mmHg at 25°C |
Index of Refraction | 1.631 |
Storage condition | 2-8℃ |
Precursor 0 | |
---|---|
DownStream 1 | |